GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (FRA:JSS) » Definitions » E10

Nxera Pharma Co (FRA:JSS) E10 : €-0.05 (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Nxera Pharma Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Nxera Pharma Co's adjusted earnings per share data for the three months ended in Jun. 2024 was €-0.093. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.05 for the trailing ten years ended in Jun. 2024.

During the past 12 months, Nxera Pharma Co's average E10 Growth Rate was -208.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Nxera Pharma Co was -43.60% per year. The lowest was -43.60% per year. And the median was -43.60% per year.

As of today (2024-12-11), Nxera Pharma Co's current stock price is €7.20. Nxera Pharma Co's E10 for the quarter that ended in Jun. 2024 was €-0.05. Nxera Pharma Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Nxera Pharma Co was 1167.62. The lowest was 32.58. And the median was 250.75.


Nxera Pharma Co E10 Historical Data

The historical data trend for Nxera Pharma Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co E10 Chart

Nxera Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 0.03 0.07 0.08 -0.01

Nxera Pharma Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.04 -0.05 -

Competitive Comparison of Nxera Pharma Co's E10

For the Biotechnology subindustry, Nxera Pharma Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nxera Pharma Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Shiller PE Ratio falls into.



Nxera Pharma Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nxera Pharma Co's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.093/108.2000*108.2000
=-0.093

Current CPI (Jun. 2024) = 108.2000.

Nxera Pharma Co Quarterly Data

per share eps CPI Adj_EPS
201409 0.017 98.500 0.019
201412 0.029 97.900 0.032
201503 0.035 97.900 0.039
201506 -0.125 98.400 -0.137
201509 -0.023 98.500 -0.025
201512 0.376 98.100 0.415
201603 -0.477 97.900 -0.527
201606 1.389 98.100 1.532
201609 -0.056 98.000 -0.062
201612 0.007 98.400 0.008
201703 -0.110 98.100 -0.121
201706 0.035 98.500 0.038
201709 -0.108 98.800 -0.118
201712 -0.128 99.400 -0.139
201803 -0.097 99.200 -0.106
201806 -0.160 99.200 -0.175
201809 -0.208 99.900 -0.225
201812 -0.272 99.700 -0.295
201903 0.106 99.700 0.115
201906 -0.067 99.800 -0.073
201909 0.116 100.100 0.125
201912 -0.003 100.500 -0.003
202003 -0.081 100.300 -0.087
202006 -0.147 99.900 -0.159
202009 0.047 99.900 0.051
202012 0.314 99.300 0.342
202103 -0.110 99.900 -0.119
202106 -0.106 99.500 -0.115
202109 0.044 100.100 0.048
202112 0.271 100.100 0.293
202203 -0.194 101.100 -0.208
202206 -0.127 101.800 -0.135
202209 0.027 103.100 0.028
202212 0.308 104.100 0.320
202303 -0.120 104.400 -0.124
202306 -0.052 105.200 -0.053
202309 -0.379 106.200 -0.386
202312 -0.014 106.800 -0.014
202403 -0.225 107.200 -0.227
202406 -0.093 108.200 -0.093

Add all the adjusted EPS together and divide 10 will get our e10.


Nxera Pharma Co  (FRA:JSS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Nxera Pharma Co was 1167.62. The lowest was 32.58. And the median was 250.75.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Nxera Pharma Co E10 Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Nxera Pharma Co Business Description

Traded in Other Exchanges
Address
Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).

Nxera Pharma Co Headlines

No Headlines